ESTROGENS,VAGINAL

Known as: Vaginal estrogen, estrogen vaginal, vaginal estrogens 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
012320142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Many providers recommend concurrent estrogen therapy with pessary use to limit complications; however, limited data exist to… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2016
2016
OBJECTIVE In the years after the 2002 publication of results from the Women's Health Initiative study, there has been a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
Atrophic vaginitis represents a major barrier to compliance with aromatase inhibitor (AI) therapy in breast cancer (BC) survivors… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
OBJECTIVE Pelvic organ prolapse is often co-existant with atrophy of the genital tract in older women who tend to prefer vaginal… (More)
Is this relevant?
Review
2015
Review
2015
OBJECTIVE To conduct a literature review of the efficiency of vaginal local estrogenotherapy (LE) on genitourinary disorders… (More)
Is this relevant?
2014
2014
OBJECTIVES To assess the patterns of use of reimbursed systemic hormone therapy (HT) and vaginal estrogen preparations among… (More)
  • table 1
Is this relevant?